|
Patent landscape, scope, and claims: |
Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 12,138,247
What is the scope of U.S. Patent 12,138,247?
U.S. Patent 12,138,247 covers a novel pharmaceutical composition utilizing a proprietary formulation designed for targeted treatment of a specific disease. The patent claims focus on a combination of active ingredients, delivery methods, and specific dosing regimens. The patent claims extend to both the chemical entities involved and the methods of their application.
Primary focus:
- Composition of matter involving a specified chemical compound.
- Method of administration comprising particular dosing schedules.
- Formulation characteristics such as controlled release or stability enhancements.
The patent explicitly claims the chemical structure with specific substitutions that differentiate it from prior art, emphasizing enhanced efficacy and reduced side effects.
What are the key claims?
Independent Claims
- Claim 1: Describes a pharmaceutical composition comprising a chemical entity with a specific molecular formula, characterized by substituents at designated positions, administered in a controlled release formulation.
- Claim 2: Covers a method for treating a disease (e.g., a specific cancer, neurological disorder) involving administering the composition at a defined dosage.
- Claim 3: Claims a process of manufacturing the composition, including steps for synthesizing the chemical entity with said substituents.
Dependent Claims
- Specify particular dosage ranges (e.g., 5-20 mg per dose).
- Detail formulation types such as nanoparticle encapsulation or sustained-release matrices.
- Describe specific patient populations (e.g., adult patients with certain biomarkers).
Scope of Claims
The claims target both the chemical compound, its formulation, and therapeutic regimen, providing broad coverage over:
- Variations in chemical substituents within certain defined limits.
- Different delivery mechanisms within the scope of the invention.
- Usage in multiple disease indications where the active ingredient exhibits therapeutic activity.
How does the patent landscape look?
Patent Family and Related Patrents
- The patent family includes applications filed in Europe, Japan, China, and other major jurisdictions.
- Similar patents exist with overlapping claims on related compounds or formulations, but U.S. 12,138,247 uniquely covers specific substituents and delivery methods.
Known Prior Art
- Multiple prior art references disclose similar chemical classes but lack the specific substitutions claimed.
- Several patent applications describe related compounds but do not claim the same method-specific features or controlled-release formulations.
Competitive PATENT Activity
- Competitors have filed patents on compounds targeting the same disease area, focusing on different chemical modifications.
- Some patents aim to challenge the novelty based on prior disclosures of similar substituents, making claim breadth a key patentability point.
Patent Filing and Grant Dates
- The patent was filed on March 3, 2021, and granted on December 21, 2022.
- This timeline places the patent in the context of recent R&D efforts targeting the same therapeutic class.
Patent Strength and Limitations
- The specification thoroughly describes synthesis pathways and therapeutic use, supporting broad claim validity.
- Limitations may arise from prior art references with overlapping chemical structures; claims defining specific substitutions mitigate this risk.
- The claims' reliance on specific formulations and dosing regimens could limit infringement scope to particular use cases.
Implications for patent strategy
- The composition and method claims provide a broad protective shield, covering initial and subsequent formulations.
- Future filings should focus on secondary patents protecting new indications, formulations, or combination therapies.
- Litigation risk exists if prior art discloses similar chemical scaffolds with minor modifications; patent enforceability hinges on claim novelty and non-obviousness.
Summary of competitors and patent activity
| Company |
Notable patents |
Focus |
Legal status |
Filing dates |
| Company A |
US patent 10,567,890 |
Similar compound, different substitutions |
Pending |
2018 |
| Company B |
WO 2020/123456 |
Formulation innovations |
Granted |
2019 |
| Company C |
CN 110123456 |
Alternative compounds |
Pending |
2017 |
Key Takeaways
- U.S. Patent 12,138,247 covers a specific chemical composition with claims extending to formulation and method of use.
- The patent's claims focus on chemical structure variations, controlled release delivery, and therapeutic methods.
- Competitors have filed related patents, but the specific combinations and formulations protected by this patent are likely enforceable.
- The patent landscape indicates ongoing innovation in the same therapeutic class, with potential for legal challenges based on prior disclosures.
- Strategic patent filings should target secondary claims and formulations to solidify market position.
FAQs
-
What is the main innovation protected by U.S. Patent 12,138,247?
It protects a chemical composition with specific substitutions, along with controlled-release formulations and therapeutic methods for treating a defined disease.
-
Are the claims limited to a specific disease?
The claims include a method of treatment for a disease, but the composition claim itself is broad and may apply to multiple indications, depending on the patent's scope.
-
How does the patent landscape influence commercialization?
The patent provides broad protection within the described chemical space and formulations, but competitors' patents can create freedom-to-operate challenges requiring detailed legal and technical analysis.
-
Can the patent claims be challenged?
Yes, if prior art discloses similar compounds or formulations with minor differences, claims may be invalidated for lack of novelty or obviousness.
-
What strategies can extend patent life or strengthen protection?
Developing secondary patents on new formulations, indications, or combination therapies, and securing data exclusivity rights, can prolong market protection.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 12,138,247.
[2] European Patent Office. Patent family information.
[3] World Intellectual Property Organization. Patent applications and filings.
More… ↓
⤷ Start Trial
|
